search

Active clinical trials for "Waldenstrom Macroglobulinemia"

Results 331-336 of 336

OCT and OCTA Deep Learning in Waldenström's Macroglobulinemia Patients

Waldenstrom Macroglobulinemia

This study evaluates the ability of deep learning to improve the knowledge about structural and vascular retinal changes in Waldenström's Macroglobulinemia patients, using optical coherence tomography angiography.

Completed11 enrollment criteria

Covid-19 Vaccine Responsiveness in MM and Waldenstrom

Multiple MyelomaWaldenstrom Macroglobulinemia2 more

This research is being done to see if the immune (defense) system of people with Multiple Myeloma and Waldenstrom's Macroglobulinemia reacts to the COVID-19 vaccine.

Unknown status11 enrollment criteria

Collecting Stem Cells in Patients With Waldenstrom's Macroglobulinemia

Lymphoma

RATIONALE: Collecting and storing stem cells to study in the laboratory may help doctors learn more about collecting stem cells from patients who have undergone treatment for Waldenstrom's macroglobulinemia. PURPOSE: This laboratory study is collecting stem cells from patients with Waldenstrom's macroglobulinemia.

Unknown status12 enrollment criteria

A Single-Arm, Expanded Access Study of Zanubrutinib in Participants With B-cell Malignancies

Waldenström Macroglobulinemia

This is a multicenter expanded access study of zanubrutinib monotherapy for participants with B-cell malignancies who are ineligible to enroll into any available zanubrutinib clinical trials

No longer available23 enrollment criteria

Expanded Access Program for Pirtobrutinib for Participants With B-Cell Cancer

LeukemiaLymphocytic10 more

This is an expanded access program for eligible participants with a previously treated B-cell cancer who are ineligible for an ongoing pirtobrutinib clinical trial. The treating physician/investigator contacts Lilly when, based on their medical opinion, a patient meets the criteria for inclusion in the expanded access program.

Available13 enrollment criteria

B-cell Chronic Lymphoid Malignancies Markers

Chronic Lymphocytic LeukemiaMarginal Zone Lymphoma4 more

Lymphoid chronic B-cell malignancies are frequent pathologies that affect adults, with a very variable prognosis and treatment (some of them can remain untreated). The diagnosis of these malignancies relies on the study of the morphology of tumoral cells and the expression by these cells of several markers, mainly via a technical approach called flow cytometry. Because the markers currently used remain imperfect, additional ones are needed for an accurate diagnosis that affect both prognosis and treatment. In addition, because numerous markers are used at the diagnosis, there is a need of tools that synthetize the multi-dimensional structure of the data obtained. The primary purpose of this study is to detect new markers that can be of help for the diagnosis of Marginal Zone Lymphoma and other B-cell chronic lymphoid malignancies. The secondary purpose of this study is to obtain a statistical algorithm that allow a good prediction of the different sub-types of chronic B-cell malignancies mainly using the results of flow cytometry.

Unknown status5 enrollment criteria
1...3334

Need Help? Contact our team!


We'll reach out to this number within 24 hrs